Elucidating the pathophysiological significance of circulating omentin levels: Is higher better?

Atherosclerosis

Volumn 251, Issue , 2016, Pages 522-524

  Cheng, Xianwu ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

Adipokine; Biomarker; Ementin 1; Ischemic heart disease; Stroke

Indexed keywords

ADIPONECTIN; APELIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; METFORMIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE HEART INFARCTION; ADIPOSE TISSUE; AMINO ACID SEQUENCE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COHORT ANALYSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; INTRAPERITONEAL FAT; ISCHEMIC HEART DISEASE; METABOLIC DISORDER; NONHUMAN; NOTE; PANETH CELL; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; WAIST CIRCUMFERENCE;

EID: 84977123186     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.06.042     Document Type: Note

References (27)

1. [1] De Jager, S.C., Pasterkamp, G., Atheroprotective properties of human Omentin-1 in experimental atherosclerosis. Cardiovasc. Res. 110 (2016), 1–3.
2. [2] Makki, K., Froguel, P., Wolowczuk, I., Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm., 2013, 139239.
3. [3] Berg, A.H., Scherer, P.E., Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96 (2005), 939–949.
4. [4] Komiya, T., Tanigawa, Y., Hirohashi, S., Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem. Biophys. Res. Commun. 251 (1998), 759–762.
5. [5] Schaffler, A., Neumeier, M., Herfarth, H., Furst, A., Scholmerich, J., Buchler, C., Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim. Biophys. Acta 1732 (2005), 96–102.
6. [6] Tsuji, S., Uehori, J., Matsumoto, M., et al. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J. Biol. Chem. 276 (2001), 23456–23463.
7. [7] Hiramatsu-Ito, M., Shibata, R., Ohashi, K., et al. Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovasc. Res. 110 (2016), 107–117.
8. [8] Matsuo, K., Shibata, R., Ohashi, K., et al. Omentin functions to attenuate cardiac hypertrophic response. J. Mol. Cell Cardiol. 79 (2015), 195–202.
9. [9] Uemura, Y., Shibata, R., Kanemura, N., et al. Adipose-derived protein omentin prevents neointimal formation after arterial injury. FASEB J. 29 (2015), 141–151.
10. [10] Watanabe, K., Watanabe, R., Konii, H., et al. Counteractive effects of omentin-1 against atherogenesisdagger. Cardiovasc. Res. 110 (2016), 118–128.
11. [11] Golabek, K., Ostrowska, Z., Ziora, K., et al. Association between omentin-1, bone metabolism markers, and cytokines of the RANKL/RANK/OPG system in girls with anorexia nervosa. Endokrynol. Pol. 66 (2015), 514–520.
12. [12] Shen, X.D., Zhang, L., Che, H., et al. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer. Cytokine 77 (2016), 50–55.
13. [13] Uygur, F., Tanriverdi, H., Can, M., et al. Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea. Sleep. Breath., 2016, 8907314, 10.1155/2016/8907314.
14. [14] Shibata, R., Ouchi, N., ikuchi, R., et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219 (2011), 811–814.
15. [15] Yoo, H.J., Hwang, S.Y., Hong, H.C., et al. Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus. Endocrine 44 (2013), 680–687.
16. [16] Yoo, H.J., Hwang, S.Y., Hong, H.C., et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc. Diabetol., 10, 2011, 103.
17. [17] Alkuraishy, H.M., Al-Gareeb, A.I., New insights into the role of metformin effects on serum Omentin-1 levels in acute myocardial infarction: cross-sectional study. Emerg. Med. Int., 2015, 283021.
18. [18] Narumi, T., Watanabe, T., Kadowaki, S., et al. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovasc. Diabetol., 13, 2014, 84.
19. [19] Menzel, J., di Giuseppe, R., Biemann, R., et al. Omentin-1 and risk of myocardial infarction and stroke: results from the EPIC-Potsdam cohort study. Atherosclerosis, 2016, 10.1016/j.atherosclerosis.
20. [20] de Souza Batista, C.M., Yang, R.Z., Lee, M.J., et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56 (2007), 1655–1661.
21. [21] Zhong, X., Zhang, H.Y., Tan, H., Zhou, Y., Liu, F.L., Chen, F.Q., Shang, D.Y., Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol. Sin. 32 (2011), 873–878.
22. [22] Herder, C., Ouwens, D.M., Carstensen, M., et al. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study. Eur. J. Endocrinol. 172 (2015), 423–432.
23. [23] Saely, C.H., Leiherer, A., Muendlein, A., et al. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Atherosclerosis 244 (2016), 38–43.
24. [24] Jiang, H., Zhao, G., Li, X., et al. Association between omentin and echo parameters in patients with chronic heart failure. Minerva Cardioangiol., 2016 Jun 8. [Epub ahead of print].
25. [25] Van Berendoncks, A.M., Garnier, A., Ventura-Clapier, R., Conraads, V.M., Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure. Heart Fail Rev. 18 (2013), 557–566.
26. [26] Maruyama, S., Shibata, R., Ohashi, K., et al. Adiponectin ameliorates doxorubicin-induced cardiotoxicity through Akt protein-dependent mechanism. J. Biol. Chem. 286 (2012), 32790–32800.
27. [27] Kataoka, Y., Shibata, R., Ohashi, K., et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J. Am. Coll. Cardiol. 63 (2014), 2722–2733.